Blood Banks and Blood Centers (BB/BC) are playing a key role in the advancement of cell and biotherapies. BB/BC are working with pharmaceutical companies as our community advances these therapies to enhance the quality and safety of patient care. This demand necessitates infrastructure development at BB/BC. In this session the speakers will share experiences from 2 BB/BC. They will share their experiences including (1) contracts and budgets, (2) developing pricing, (3) information technology (IT) needs and challenges for Blood Establishment Computer System (BECS) tracking to integrating International Society of Blood Transfusion (ISBT) requirements and (4) how to track and handle compliance among different companies.
To view Spanish or English subtitles, click the "CC" box in the video player. Para ver subtítulos en español o inglés, haga clic en el cuadro "CC" en el reproductor de video.
Identify infrastructure needs for Blood Banks and Blood Centers (BB/BC) to develop a cell and biotherapy program.
Describe actions to overcome some of the challenges faced by BB/BC
List key items for developing a budget in a contract with a pharmaceutical company
MD, MBA, MSEd,
University Hospitals, Samaritan Medical Center and Case Western
All relevant financial relationships have been mitigated. By completing the evaluation, you are attesting to watching the presentation in its entirety. A certificate will be immediately provided after submission.
AM21-23: Creating the Blood Center Infrastructure for Biotherapies: From Contracts to Collections and Distribution Evaluation